Skip to main content
J.B. Chemicals & Pharmaceuticals Lt logo

J.B. Chemicals & Pharmaceuticals Lt — Investor Relations & Filings

Ticker · JBCHEPHARM ISIN · INE572A01036 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2026-05-25 Environmental & Social …
Country IN India
Listing BSE.NS JBCHEPHARM

About J.B. Chemicals & Pharmaceuticals Lt

https://jbpharma.com/

J.B. Chemicals & Pharmaceuticals Ltd, operating as JB Pharma, specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations and active pharmaceutical ingredients. The company holds a strong market position in therapeutic areas including cardiology, gastroenterology, anti-infectives, and dermatology. Its product portfolio features prominent brands such as Cilacar, Metrogyl, and Rantac. With a focus on high-quality production, the organization operates multiple manufacturing sites that comply with global regulatory standards. JB Pharma serves a broad international client base across regions such as Russia, the CIS, Southeast Asia, and Africa, leveraging its research and development capabilities to provide specialized healthcare solutions and maintain a competitive edge in global markets.

Recent filings

Filing Released Lang Actions
BRSR for FY 26
Environmental & Social Information Classification · 95% confidence The document is titled “Business Responsibility and Sustainability Report” for the financial year 2025-26 and contains non-financial disclosures on environmental, social, and governance principles (e.g., ESG metrics, sustainability initiatives, stakeholder engagement). It is a standalone sustainability/ESG report rather than a financial statement or regulatory filing of another type. This matches the Environmental & Social Information category.
2026-05-25 English
Annual Report for FY 26
Annual Report Classification · 98% confidence The document is labeled as the “Integrated Annual Report for the year 2025-26” submitted under SEBI Regulation 34 and includes extensive sections typical of a full annual report: MD’s message, corporate overview, statutory reports, and detailed financial highlights and statements. It contains actual financial performance data (revenue, EBITDA, PAT) and corporate governance information, not merely an announcement of availability. Therefore, it is the full Annual Report. FY 2026
2026-05-25 English
Intimation of Notice of AGM to be held on June 17, 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal Notice of the 50th Annual General Meeting sent to shareholders, outlining the date, time, venue, agenda items (ordinary business), dividend proposals, director appointments, e-voting procedures, and participation details. It is not the AGM minutes or a report, nor is it announcing results. It is a solicitation of votes and information for the upcoming AGM, fitting the Proxy Solicitation & Information Statement category.
2026-05-25 English
Shareholders meeting
Regulatory Filings Classification · 85% confidence The document is a formal Notice of the 50th Annual General Meeting issued under SEBI LODR Regulation 30 and filed with the stock exchange. It does not contain financial statements or results nor is it a report itself, proxy statement, or presentation material from the AGM. Rather, it is a regulatory announcement of the meeting. Thus it falls under the catch-all “Regulatory Filings” category.
2026-05-25 English
Disclosure of Annual Secretarial Compliance Certificate for the financial year ended March 31, 2026
Regulatory Filings Classification · 90% confidence The document is a Secretarial Compliance Certificate under SEBI LODR Regulations, issued by a Practicing Company Secretary confirming compliance with listing obligations for the financial year ended March 31, 2026. It is an officer attestation/certification letter and does not itself contain substantive financial statements or constitute an Annual/Quarterly Report. Under the certification rule, such attestation letters are classified as general regulatory filings. Therefore, the correct category is Regulatory Filings (RNS).
2026-05-22 English
Record Date
Notice of Dividend Amount Classification · 92% confidence The document is an intimation to the stock exchange under SEBI LODR Regulation 42 setting a record date to determine eligibility for the final dividend for FY 2025-26. This is a shareholder-facing notice about dividend-related timing. It does not present financial statements or management discussion, but specifically announces dividend details (record date). This matches the “Notice of Dividend Amount” category.
2026-05-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.